Status: Recruiting
Zimmer Biomet Shoulder Arthroplasty PMCF
The objectives of this study are to confirm the safety, performance, and clinical benefits of Zimmer Biomet Shoulder Arthroplasty Systems and its instrumentation in primary or revision shoulder arthroplasty. These objectives will be assessed using standard scoring systems, radiographic evidence, and adverse event records. Safety of the system will be assessed by monitoring the frequency an incidence of adverse events.
Participants needed: 584
Trial details
Age: 20+Biological sex: AllType: InterventionalSponsor: Zimmer BiometUpdated: Apr 28, 2026Locations: 17
Eligibility criteria
Patient must be 20 years of age or older. [+12]
Patient is unwilling or unable to give consent or to comply with the follow-up p... [+14]